School of Medicine
Showing 2,601-2,700 of 4,417 Results
-
Marco Antonio Monroy
Associate Director for Biosciences Graduate Education Initiatives, School of Medicine - Grad Student Support
Current Role at StanfordDirector, Biosciences ADVANCE Institute
Associate Director for Stanford Biosciences Graduate Education Initiatives -
Christine Morton
Research Sociologist, Pediatrics - Neonatology
Current Role at StanfordResearch Sociologist at California Maternal Quality Care Collaborative (CMQCC) & California Perinatal Quality Care Collaborative (CPQCC)
-
Tia Moscarello, MS, LCGC
Staff, Medicine - Med/Cardiovascular Medicine
Clinical Assistant Professor (Affiliated), Pediatrics - GeneticsBioLicensed and certified genetic counselor with a specialization in inherited cardiovascular disease. Primary genetic counselor for the first on-call cardiovascular genetic counseling service. Clinical instructor for the Stanford University MS in Human Genetics and Genetic Counseling Program.
-
Dora G. Moscoso
AA and Postdoc Coordinator, Medicine - Med/Blood and Marrow Transplantation
Current Role at StanfordAA/Postdoctoral Fellowship Coordinator
-
Patricia Moussatche
CTSA Hub QA/QC Project Manager, Translational Research Operations
Current Role at StanfordCTSA Hub QA/QC Program Manager
-
Meagan Moyer
Lecturer, Medicine - Primary Care and Population Health
BioI am a lecturer in the School of Medicine's Clinical Informatics Management master of science program. I co-instruct the autumn through spring quarters practicum courses. Students in my courses gain a foundational knowledge of health policy, learn from experts in the field of health technology, and complete a capstone project that brings together learnings from the entire program into a meaningful deliverable that furthers their career and the field of clinical informatics and digital health technology.
-
Julie Muccini, MS, OTR/L
Research Engineer, Rad/Musculoskeletal Imaging
BioJulie Muccini is an occupational therapist who has spent most of her clinical career working with individuals with neurological diagnoses. She is registered and licensed in California and is a member of the American Occupational Therapy Association (AOTA) and the Occupational Therapy Association of California (OTAC). She is actively involved in research working with individuals post-stroke, neuromuscular diseases, and osteoarthritis; additional work includes assessing shoulder movements, sprinting, and balancing tasks; she works in the Human Performance Lab with an interdisciplinary team integrating biomechanics, biomedical engineering, physiology, psychology, and rehabilitation. Ms. Muccini received her bachelor of science in industrial engineering and operations research from the University of Massachusetts at Amherst and her master of science in occupational therapy from Boston University. She started working at the hospital at Stanford in 1997 and transitioned to the Outpatient Neuro Rehab Clinic at the Stanford Neurosciences Health Center in 2014. In March 2021, Julie moved to the Stanford University School of Medicine to work in the Human Performance Lab at the Arrillaga Center for Sports and Recreation, ACSR, as a Wu Tsai Human Performance Alliance member.
-
Pavithra Mukunda
Clinical Rsch Mgr, Psych/Public Mental Health & Population Sciences
Current Role at StanfordClinical Research Manager
-
Liam Edward Mulhall
Software Developer, Biomedical Data Science
Current Role at StanfordLiam develops and maintains the HLA Curation Interface, a tool that supports the assessment of HLA alleles and haplotypes for use in precision medicine and research. He also works on internal tools used by the Stanford ClinGen team.
-
Martin Stefan Mumenthaler
Adjunct Professor, Psych/Public Mental Health & Population Sciences
BioMartin Mumenthaler has a PharmD and a PhD in psychopharmacology from the University of Bern, Switzerland. He holds an appointment as Adjunct Professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine where he has been conducting research programs in addiction medicine and psychopharmacology, and teaching and mentoring medical students and residents on a voluntary basis.
Dr. Mumenthaler has also been working in various full-time positions in the pharmaceutical industry as Director in Clinical Development as well as in Medical Affairs, and as a consultant for early-stage pharma- and biotech companies providing advice on designing and conducting clinical trials, and analyzing and interpreting study results, mainly in the field of addiction medicine and pain.
His academic research has focused on the effects of psychoactive drugs on human performance, Aerospace Medicine, Alzheimer’s disease, and addiction medicine, and in these areas he has presented his results internationally and published over twenty-five peer-reviewed scientific articles. He has also served as a reviewer for various scientific journals, and is a member of the Research Society on Alcoholism, and an Associate Fellow of the Aerospace Medical Association. -
Gabriella Muwanga
Temp - Non-Exempt, Anesthesia - Adult Pain Medicine
BioGabriella Muwanga is a Neurosciences graduate student in the Tawfik and Airan labs at Stanford. She is interested in understanding acute and chronic pain mechanisms and developing therapies for acute and chronic pain through basic and translational research. Gabriella holds a Bachelor of Science in Biomedical Sciences from Makerere University, Kampala, Uganda. She is passionate about teaching, mentorship, science communication, and fostering diversity in science. Outside the lab, she enjoys writing, singing, drawing, Bible Study, and fellowship.
-
Jonathan N. Myers
Clinical Professor (Affiliated), Medicine - Med/Cardiovascular Medicine
BioDr. Myers is a Health Research Scientist at the Palo Alto VA Health Care System; a Clinical Professor at Stanford University (Affiliated), and a Senior Research Career Scientist Award recipient through the VA Rehabilitation Research and Development Program. His research has focused on primary and secondary prevention, and the clinical applications of exercise testing and rehabilitation in patients with cardiovascular disease and other chronic conditions. He has a lengthy history of studying the epidemiology of cardiopulmonary exercise test responses, physical activity patterns, and other lifestyle factors and their relation to health outcomes. He manages the Veterans Exercise Testing Study (VETS), an ongoing, prospective evaluation of Veteran subjects referred for exercise testing for clinical reasons, designed to address exercise test, clinical, and lifestyle factors and their association with health outcomes.
He earned his bachelor’s degree from the University of California, Santa Barbara, his master's degree from San Diego State University, and his doctorate from the University of Southern California. He has been a board member for many organizations including the American Heart Association (AHA), the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR), and the American College of Sports Medicine (ACSM), and serves on the editorial board for 9 journals. He is a recipient of the Michael Pollock Established Investigator Award through the AACVPR, a recipient of the Steven N Blair Award for excellence in physical activity research from the AHA Council on Epidemiology and Prevention and is the 2022 recipient of the American College of Sports Medicine Citation Award. He is a fellow of the AACVPR, ACSM, American College of Cardiology, and the AHA, and has authored and co-authored guidelines on exercise testing and rehabilitation for each of these organizations, including the 2021 editions of the ACSM and AACVPR guidelines. -
Ronjon Nag, PhD
Adjunct Professor, Genetics
BioRonjon Nag is an inventor, teacher and entrepreneur. He is an Adjunct Professor in Genetics at the Stanford School of Medicine, becoming a Stanford Distinguished Careers Institute Fellow in 2016. He teaches AI, Genes, Ethics, Longevity Science and Venture Capital. He is a founder and advisor/board member of multiple start-ups and President of the R42 Group, a venture capital firm which invests in, and creates, AI and Longevity companies. As an AI pioneer of smartphones and app stores, his companies have been sold to Apple, BlackBerry, and Motorola. More recently he has worked on the intersection of AI and Biology. He has been awarded the IET Mountbatten Medal by the Institution of Engineering and Technology, the 2021 IEEE-SCV Outstanding Engineer Award, the $1m Verizon Powerful Answers Award, the 2023 COGX AI Lifetime Achievement Award, the 2023 MIT Great Dome Award, and was the 2024 Inductee in the Silicon Valley Engineering Hall of Fame. Professor Nag has a Ph.D from Cambridge, an M.S from Massachusetts Institute of Technology and a B.Sc. from Birmingham in the UK. He has numerous interests in the intersection of AI and Healthcare including being CEO of Agemica.ai working on creating a vaccine for aging.
He has many firsts including:
Firsts:
• First laptop with speech recognition built-in (with Apricot, 1984)
• First selling cursive handwriting recognition (with Lexicus, 1991)
• First speech recognition phones (with Lexicus/Motorola, 1996)
• First large-vocabulary Chinese speech recognition (with Lexicus/Motorola, 1996)
• First Chinese predictive text system on a phone (Lexicus/Motorola, 1997)
• First predictive text systems in 40 languages on Motorola phones, (Lexicus/Motorola, 1997)
• First touch screen mobile phone with handwriting recognition (Lexicus/Motorola, 1999)
• First combined mobile search engine and directory (with Cellmania, 2000)
• First private label downloadable operator billable apps store (Cellmania, 2000)
• First BlackBerry Operator Billing apps store (Cellmania,2010)
• First Neural Network Artificial Intelligence System in the Cloud (Ersatz Labs, 2014)
• First Throwable 360 Ball Camera (Bounce Imaging, 2015)
• First Android powered smart light switch (Brightswitch 2017)
• First blood pressure watch with temperature and pulse oximetry add-ons for Back to Work Covid Kit (GTCardio 2019)
• First no code AI life sciences app store (Superbio.ai 2022)
• First proposal for an aging vaccine (Agemica 2023)
